Atlas Trials

ImmunoGen, Inc.

16 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch ImmunoGen, Inc.

RecordFirmDate
First-in-Human Study of IMGC936 in Participants With Advanced Solid Tumors (NCT04622774)ImmunoGen, Inc.2020-10-29
A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (NCT04296890)ImmunoGen, Inc.2020-07-23

Track ImmunoGen, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.